Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Aug 21 (Reuters) - Star Combo Pharma S66.AX :
* OUTLOOK FOR FY2025 IS POSITIVE
* FINAL DIVIDEND PER SHARE A$0.0037
Further company coverage: S66.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident